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Introduction {#sec005}
============

Anemia implies a reduction in the oxygen-carrying capacity of the blood as a result of fewer circulating erythrocytes than normal or a decrease in the concentration of hemoglobin (Hb). Anemia during pregnancy is defined as a hemoglobin concentration less than 11gram per deciliter (g/dl) and classified as mild (10.0--10.9g/dl), moderate (7.0--9.9g/dl) and severe \<7g/ dl. Currently, World Health Organization (WHO) recognized that the hemoglobin value less than 11.0 g/dl at 1^st^ and 3^rd^ trimesters and less than 10.5 g/dl in the 2^nd^ trimester is used to define anemia \[[@pone.0224514.ref001]\].

Anemia is a common public health problem affecting one- third of the world's population. It is more common in women who are young, poor and pregnant \[[@pone.0224514.ref002]\]. It is among the most clinical problem contributing to increased maternal and fetal morbidity and mortality during pregnancy \[[@pone.0224514.ref003]\]. Anemia among pregnant women is more prevalent in developing countries than in developed countries \[[@pone.0224514.ref004]\].

The causes of anemia in pregnancy are multi-factorial. Iron folate, amino acids, vitamin A, C and other vitamin B complex deficiencies, intestinal helminthic infections, malaria, and chronic illnesses are among the most common causes \[[@pone.0224514.ref005]\]. The other risk factors include poverty, grand parity, too early pregnancies, too many children, frequent pregnancy spacing of less than one year, low socioeconomic status, illiteracy, late booking for antenatal care and gestational age \[[@pone.0224514.ref006], [@pone.0224514.ref007]\].

Globally, 56 million pregnant women were anemic and 20% of maternal deaths were caused by anemia. It was 35--75% among pregnant women in developing countries and 18% in developed countries. Africa (61.3%) and southeast Asia (52.5%) are regions with the highest rate of anemia during pregnancy in the world \[[@pone.0224514.ref008]\].

In Ethiopia, the prevalence of anemia among pregnant women was 22% which is more common in rural areas. According to the Central Statistical Agency of Ethiopia 2011 report \[[@pone.0224514.ref009]\], anemia is still a public health problem in the country. Anemia during pregnancy is widely distributed in different regions of Ethiopia especially in Somali (49.9%), Afar (40.4%) and Dire Dawa (33.2%).

Although a lot of researches have been conducted about anemia during pregnancy in Ethiopia, there is still a paucity of published data on determinants of anemia among pregnant women in the current study area. The study is; therefore, aimed to identify determinants of anemia among pregnant women in Horo Guduru Wollega Zone, West Ethiopia.

Materials and methods {#sec006}
=====================

Study setting and context {#sec007}
-------------------------

An institutional-based unmatched case-control study was conducted in randomly selected 8 health facilities. These facilities were Jima Rare health center, Goban health center, Kombolcha health center, Ayale health center, Harato health center, Gudane health center, site 20 health center, site 24 health center, and Shambu hospital. The study was conducted from September 7, 2017, to October 25, 2017.

Study population {#sec008}
----------------

Our study population was categorized into cases and controls. Cases were all pregnant women who were attending ANC follow up at the selected public health facilities whose Hb level fall in our anemia definition whereas controls were all pregnant women who were attending ANC follow up at the selected public health facilities whose Hb fall in our non-anemic definition. Anemia during pregnancy was defined and classified based on WHO \[[@pone.0224514.ref001]\] and Ethiopian ANC follow-up guidelines for different gestational ages. Accordingly, women in the first and third trimester whose Hb level was \< 11g/dl and women, in the second trimester, whose Hb level was \< 10.5 g/dl0 were defined to be anemic for cases. Pregnant women at any gestational age (GA) were included in the study. GA of pregnant women was classified into trimesters i.e. GA below 12 weeks: first trimester, GA of 13--24 weeks: second trimester and GA above 24 weeks: third trimester. The gestational age was calculated from last normal menstrual period (LNMP) which was determined by antenatal care providers. In Ethiopia, health extension workers register pregnant women of any GA with their last normal menstrual period at home, thus, GA is not usually missed.

Pregnant women who were taking anti-helminthic drugs within the past two weeks, very sick and unable to give information, those with confirmed acute and/ chronic disease-causing anemia and those under invasive anemia treatment except iron folate were excluded from this study.

Sample size determination and sampling procedure {#sec009}
------------------------------------------------

The sample size was calculated using OpenEpi software for unmatched case-control study by taking 95% confidence level, 80% power and a ratio of controls to cases 2:1 (r = 2), P1 = 42.03 and P2 = 57.97 by using OR = 1.9 \[[@pone.0224514.ref010]\]. Based on this, the intestinal parasitic infection was taken as the main exposure variable with a proportion of 57.97 among cases and 42.03% among controls with OR = 1.90 which gives a sample size of 347. Lastly, by considering a design effect of 1.5 and adding 10% non-response rate, the final sample size was 573. From this, cases were 191 and controls were 382. The study participants were consecutively enrolled until the planned sample size was achieved. A 2: 1 control to case ratio was applied and study participants were recruited proportionally from each health facilities based on the number of pregnant women attending ANC.

Data collection {#sec010}
---------------

The questionnaire was developed from previous literatures and modified to the current context of the study based on the conceptual framework and study variables \[[@pone.0224514.ref006], [@pone.0224514.ref010] and [@pone.0224514.ref011]\]. The questionnaire was first prepared in English language and translated to 'Afan Oromo' which is the local language at the study sites and retranslated back to English language for consistency. Before the actual data collection, the questionnaire was pre-tested on 19 pregnant women (5% of the total sample size) who were attending ANC in an un-selected health facility, Shambu health center.

Minimum Dietary Diversity for Women (MDD-W) was calculated from 24 hours' dietary recall data. All foods consumed day before the study were categorized into 10 food groups. Consuming a food item from any of the groups was assigned as" Yes" and if not consumed assigned as" No". Dietary diversity score of 10 points was computed by adding all values of the groups. Then, the added values were categorized as low (≤3), medium (4--6) and high (≥7) dietary intake \[[@pone.0224514.ref012]\]. Study participants were screened for nutritional status by measuring MUAC (Mid-Upper Arm Circumference) by using tape meter.

Specimen collection and processing {#sec011}
----------------------------------

Blood samples were collected following aseptic procedures for hemoglobin determination using microhematocrit centrifugation technique. Briefly, blood was collected into two-third of the micro-hematocrit tube with anti-coagulant and centrifuged for 5 minutes and then hemoglobin was determined by dividing hematocrit value by three \[[@pone.0224514.ref013]\]. The hemoglobin cut-off value for anemia during pregnancy was determined according to the WHO \[[@pone.0224514.ref001]\] and Ethiopian ANC follow-up guidelines. Thick and thin blood films were made from collected blood samples and stained by Giemsa staining technique for hemo-parasite diagnosis \[[@pone.0224514.ref014]\] and VDRL test \[[@pone.0224514.ref015]\] was done to identify Syphilis infection following standard operating procedures. Further, formalin-ether concentration technique was used for diagnosing ova and larvae of helminths \[[@pone.0224514.ref014]\].

Data quality control {#sec012}
--------------------

One senior midwife who was working in ANC department of each selected health facilities and three Health Officers were recruited as supervisors who were under the whole supervision of the principal investigator. Two days of training was conducted for data collectors and supervisors to aid for clarity, consistency, and reliability of measurements. Collected data were checked for consistency and completeness daily and pre-analytical, analytical and post-analytical laboratory data quality were controlled accordingly.

Data analysis {#sec013}
-------------

Data were cleaned, coded and entered into SPSS software version 20 for analysis. Outcome variables were dichotomized into 1 = case and 0 = control. Binary logistic regression models were used to determine the association between predictors and outcome variables. Bivariate analysis was carried out for each independent variable to identify the presence of association with response variable at P \< 0.25 \[[@pone.0224514.ref016]\]. Multivariate logistic regression was used to control the possible confounding factors at P ≤ 0.05. Adjusted odds ratio with 95% confidence (AOR, 95%CI) was used to infer the results and all data analyses were done according to standard protocols \[[@pone.0224514.ref017]--[@pone.0224514.ref019]\].

Ethics considerations {#sec014}
---------------------

The study was conducted after it was ethically reviewed and approved by the Research and Ethical Review Committee of Wollega University. Then, an official letter of co-operation was written to selected health facilities and permission was obtained. The ethical review committee approved informed verbal consent documented by a witness after the objectives had been explained. Participants' right during the interview for either not to participate or to withdraw at any stage of the interview was guaranteed. All the information obtained from the study participants were coded to maintain confidentiality and positive results were immediately communicated with clinicians for appropriate intervention.

Results {#sec015}
=======

Socio-demographic characteristics of study participants {#sec016}
-------------------------------------------------------

A total of 573 pregnant women participated in the study. The mean age of respondents was 27(±5.4) years in cases and 26.8 (±5) years in controls. More than half of the participants, (59.2% (113/191) of cases and 52.6% (201/382) of controls, were farmers. The proportion of anemic pregnant mothers, 44.5% (85/191) with average monthly income \< 500 ETB were more than four times of their counterparts, 10.5% (40/382) (**[Table 1](#pone.0224514.t001){ref-type="table"}**).

10.1371/journal.pone.0224514.t001

###### Sociodemographic characteristics of study participants who were attending ANC in the public health facilities of Horo Guduru Wollega Zone, West Ethiopia from September 7 to October 25, 2017 (n = 573).

![](pone.0224514.t001){#pone.0224514.t001g}

  Variables                  Frequencies (%)                     
  -------------------------- ----------------------- ----------- -----------
  Age                        15--19                  6(3.1)      20(5.2)
  20--24                     52(27.2)                91(23.8)    
  25--29                     67(35.1)                152(39.8)   
  30--34                     40(21.1)                78(13.6)    
  35--39                     21(11)                  38(10)      
  40--44                     5(2.6)                  3(0.8)      
  Marital status             Never married           3(1.6)      2(0.5)
  Married                    181(94.8)               369(96.6)   
  Widowed                    4(2.1)                  4(1)        
  Divorced                   3(1.)6                  7(1.8)      
  Residence                  Urban                   73(38.2)    168(44)
  Rural                      118(61.8)               214(56)     
  Family size                \<5                     115(60.2)   240(62.8)
  ≥5                         76(40)                  142(37.2)   
  Occupation of respondent   Governmental employee   26(13.6)    77(20.2)
  Farmer                     113(59.2)               201(52.6)   
  Merchant                   32(16.8)                58(15.2)    
  Daily laborer              11(5.8)                 14(3.7)     
  Other                      9(4.7)                  32(8.4)     
  Occupation of husband      Governmental employee   39(20.4)    98(25.7)
  Farmer                     115(60)                 199(52)     
  Merchant                   20(10.5)                55(14.4)    
  Daily laborer              13(6.8)                 23(6)       
  Other                      4(2.1)                  7(1.8)      
  Income                     \<500                   85(44.5)    40(10.5)
  500--1499                  53(27.7)                146(38.2)   
  1500--2499                 22(11.5)                54(14)      
  2500--3499                 13(6.8)                 39(10.2)    
  \>3500                     18(9.4)                 103(27)     
  Educational status         No education            59(31)      74(19.3)
  Primary school             75(39.3)                151(39.5)   
  Secondary school           24(12.6)                63(16.5)    
  Above secondary school     33(17.3)                94(24.6)    

Maternal obstetric factors {#sec017}
--------------------------

Most of the study participants, 98% (185/188) of cases and 96.3(366/380) of controls, were married with a mean age of 19(± 2.3). Clinically, 63.9% (122/191) of cases and 63% (241/382) of controls were at their third trimester. The proportion of heavy menstrual bleeding (using more than 7 tampons per menstrual period) was two times more in cases than in controls (32% and 16%, respectively) (**Table A in [S1 File](#pone.0224514.s001){ref-type="supplementary-material"}**).

Maternal dietary factors {#sec018}
------------------------

Based on the dietary diversity score, more than half of cases (66% (126/191)) and controls (67.3%(257/382)) were classified under medium dietary diversity score, whereas 4.2% (8/191) and 30% (57/191) of cases, and 26%(99/382) and 6.8%(26/382) of controls were classified under high and low dietary diversity scores, respectively (**Table B in [S1 File](#pone.0224514.s001){ref-type="supplementary-material"}**).

Infection related factors {#sec019}
-------------------------

The proportion of malaria infection was almost twelve times in cases, 6% (11/191) than controls, 0.5% (2/382). VDRL test was positive in 3.7% (14/191) of cases and 10% (19/382) of controls. Intestinal helminthic infections were diagnosed in 39.9% (76/191) of cases and 6.5% (25/382) of controls (**[Fig 1](#pone.0224514.g001){ref-type="fig"}** and **[Table 2](#pone.0224514.t002){ref-type="table"}**).

![Distribution of intestinal helminthic infection among pregnant women.](pone.0224514.g001){#pone.0224514.g001}

10.1371/journal.pone.0224514.t002

###### Diseases related factors of anemia among pregnant women who were attending ANC follow up in the selected public health facilities of Horo Guduru Wollega Zone, West Ethiopia from September 7 to October 25, 2017(n = 573).

![](pone.0224514.t002){#pone.0224514.t002g}

  Variables                       Frequencies (%)               
  ------------------------------- ----------------- ----------- ---------
  Malaria                         Yes               11(5.8)     2(0.5)
  No                              180(94.2)         380(99.5)   
  Diarrhea in the last 2 weeks    Yes               22(11.5)    21(5.5)
  No                              169(88.5)         361(94.5)   
  Syphilis infection              Yes               19(10)      14(3.7)
  No                              172 (90)          368(96.3)   
  Intestinalhelminthicinfection   Yes               76(39.9)    25(6.5)
  No                              115(60.1)         357(93.5)   
  *Ascaris Lumbricoides*          Yes               29(15)      12(6.3)
  No                              161(84.7)         371(96.8)   
  *Tricuris Trichiura*            Yes               14(7.4)     5(1.3)
  No                              176(92.6)         378(98.7)   
  *Hookworm*                      Yes               27(14)      6(1.56)
  No                              163(85.8)         377(98.4)   
  *Hymenolepis nana*              Yes               8(4.2)      4(1)
  No                              182(95.8)         379(98.9)   

Hygiene and sanitation related factors {#sec020}
--------------------------------------

Majority of the study participants i.e. 87.4% (167/191) of cases and 91.9% (350/382) of Controls utilized latrine and 70.2% (134/191) cases and 64.4% (246/382) controls used to dispose of solid waste in open field. The source of drinking water was tap water for 45.5% (87/191) of cases and 52.6% (201/382) of controls (**[Table 3](#pone.0224514.t003){ref-type="table"}**).

10.1371/journal.pone.0224514.t003

###### Hygiene and sanitation-related factors of anemia in pregnant women attended ANC follow up in the selected public health facilities of Horo Guduru Wollega Zone, West Ethiopia from September 7 to October 25, 2017 (n = 573).

![](pone.0224514.t003){#pone.0224514.t003g}

  Variables                                    Frequencies (%)               
  -------------------------------------------- ----------------- ----------- -----------
  Using latrine                                Yes               167(87.4)   351(91.9)
  No                                           24(12.6)          31(8.1)     
  Hand washing facility with latrine           Yes               36(18.8)    104(27.2)
  No                                           139(72.8)         264(72.8)   
  Solid waste disposal site                    Open-pit          41(21.5)    90(23.6)
  Open field                                   134(70.2)         246(64.4)   
  Sanitary landfill                            15(7.4)           46(12)      
  Source of drinking water                     Tap water         87(45.5)    201(52.6)
  Protected spring                             56(29.3)          115(30)     
  Unprotected spring                           32(16.8)          42(11)      
  River                                        14(7.3)           20(5.2)     
  Other                                        2(1)              4(1)        
  Treatment for the not potable water source   Yes               78(75)      150(82.8)
  No                                           79(76)            137(75.6)   
  Handwashing before food preparation          Yes               190(99)     381(96.9)
  No                                           1(0.5)            1(0.3)      

Status of anemia {#sec021}
----------------

Mild anemia was the most prevalent form of anemia accounting for 60% followed by moderate anemia 39% and severe anemia 1%. The mean hemoglobin level was 9.7 ± 0.69 gm/dl among the cases and 13 ± 1.1 gm/dl among control groups.

Inferential statistics {#sec022}
----------------------

Multivariable binary logistic regression analysis was done to identify independent predictors of anemia at P ≤ 0.05. Hosmer and Lemeshow goodness of model fit test showed a good model fit (P = 0.98) and the VIF of covariates in this study ranged between 1--1.2 which is in the acceptable range for multicollinearity which means there was no correlation among predictors of anemia and; therefore, there was no correlation between gestational age and other risk factors of anemia. This indicates that risk factors of anemia were not changeable based on differences in gestational age.

Average monthly income \< 500 ETB showed statistically significant association with anemia among pregnant women (AOR = 9.16, 95% CI: 4.23, 19.82). Anemia was more prevalent among those with heavy menstrual bleeding before index pregnancy than their counterparts (AOR = 2.38, 95%CI: 1.38, 4.09). Pregnant women who took iron supplements irregularly were almost 3 times more likely to be anemic than their counterparts (AOR = 2.87, 95%CI: 1.41, 5.84). A strong association was also seen between the occurrence of anemia and low dietary diversity score of 24 hours recall (AOR = 12.3, 95%CI: 4.64, 32.72). Likewise, there was also a significant association between medium DDS and occurrence of anemia among pregnant women (AOR = 3.40, 95%CI: 1.48, 7.84). Gestational age was not significant predictor of anemia (P \> 0.05) (**[Table 4](#pone.0224514.t004){ref-type="table"}**).

10.1371/journal.pone.0224514.t004

###### Multivariate binary logistic regression analysis of determinants of anemia among pregnant women in the selected public health facilities of Horo Guduru Wollega Zone, West Ethiopia from September 7 to October 25, 2017(n = 573).

![](pone.0224514.t004){#pone.0224514.t004g}

  Variables                        Frequencies(%)   COR(95%CI)   AOR(95%CI)                                              P value                                                                                                
  -------------------------------- ---------------- ------------ ------------------------------------------------------- ------------------------------------------------------- ---------------------------------------------- --------------------------------------------------
  Income                           \<500            85(44.5)     40(10.5)                                                12.16(6.5,22.74)[\*](#t004fn001){ref-type="table-fn"}   9.16(4.23,19.82)                               \<0.001[\*\*\*](#t004fn003){ref-type="table-fn"}
  500--1499                        53(27.7)         146(38.2)    2.08(1.15, 3.75)[\*](#t004fn001){ref-type="table-fn"}   1.83(0.88, 3.81)                                        0.11                                           
  1500--2499                       22(11.5)         54(14)       2.33(1.15, 4.72)[\*](#t004fn001){ref-type="table-fn"}   1.83(0.78, 4.29)                                        0.17                                           
  2500--3499                       13(6.8)          39(10.2)     1.91(0.86, 4.26)                                        2.53(0.97, 6.63)                                        0.06                                           
  \>3500                           18(9.4)          103(27)      1                                                       1                                                                                                      
  Menstrual period                 ≥8 days          46(24)       32(8.4)                                                 3.5(2.12, 5.67)[\*](#t004fn001){ref-type="table-fn"}    2.11(0.97, 4.59)                               0.06
  \<8 days                         145(76)          350(91.6)    1                                                       1                                                                                                      
  Heavy menstrual bleeding         Yes              61(31.9)     61(16)                                                  2.47(1.64, 3.72)[\*](#t004fn001){ref-type="table-fn"}   2.38(1.38, 4.09)                               0.002[\*\*](#t004fn002){ref-type="table-fn"}
  No                               130(68.4)        321(83.8)    1                                                       1                                                                                                      
  Parity                           Nulliparous      53(28)       132(34.5)                                               1                                                       1                                              
  Primipara                        40(20.9)         80(20.9)     1.24(0.76, 2.04)                                        2.52(0.99, 6.44)                                        0.054                                          
  Multipara                        45(23.7)         92(24)       1.22(0.76,1.97)                                         1.82(0.72, 4.59)                                        0.20                                           
                                   Grandpara        53(28)       78(20.4)                                                1.69(1.06, 2.72)[\*](#t004fn001){ref-type="table-fn"}   2.28(0.91, 5.74)                               0.08
  Abortion                         Yes              28(14.7)     34(8.9)                                                 1.76(1.03, 2.99)[\*](#t004fn001){ref-type="table-fn"}   0.92(0.44, 1.94)                               0.83
  No                               163(85.3)        348(91)      1                                                       1                                                                                                      
  Birth interval                   \<2 years        26(13.7)     21(5.5)                                                 2.87(1.55, 5.30)[\*](#t004fn001){ref-type="table-fn"}   2.22(0.85, 5.76)                               0.10
  ≥2 years                         116(61)          272(71)      1                                                       1                                                                                                      
  ANC follow up                    Yes              147(77)      350(91.6)                                               1                                                       1                                              
  No                               44(23)           32(8.4)      3.27(1.99, 5.37)[\*](#t004fn001){ref-type="table-fn"}   1.99(0.75, 5.31)                                        0.17                                           
  Trimester                        First            12(6.3)      42(11)                                                  1                                                                                                      
  Second                           55(29)           120(31.3)    1.47(0.96, 2.24)                                                                                                                                               
  Third                            123(64.7)        221(57.7)    1.41(0.79, 2.51)                                                                                                                                               
  Bleeding                         Yes              22(11.6)     13(3.4)                                                 3.7(1.82,7.51)[\*](#t004fn001){ref-type="table-fn"}     1.25(0.41, 3.76)                               0.69
  No                               169(88.5)        369(96.6)    1                                                                                                                                                              
  Nausea and vomiting              Yes              63(33)       89(23.3)                                                1.62(1.10, 2.38)[\*](#t004fn001){ref-type="table-fn"}   0.98(0.54, 1.82)                               0.97
  No                               128(67)          293(76.7)    1                                                       1                                                                                                      
  Took iron                        Yes              104(54.5)    273(71.5)                                               1                                                       1                                              
  No                               87(45.8)         109(28.5)    2.09(1.46, 3.01)[\*](#t004fn001){ref-type="table-fn"}   1.29(0.69, 2.39)                                        0.43                                           
  Taking iron supplement daily     Yes              63(60.6)     239(87.6)                                               1                                                       1                                              1
  No                               41(39.4)         34(12.4)     4.58(2.69, 7.79)[\*](#t004fn001){ref-type="table-fn"}   2.87(1.41, 5.84)                                        0.004[\*\*](#t004fn002){ref-type="table-fn"}   
  Frequency of eating vegetables   ≤3/week          56(29.3)     175(45.8)                                               1                                                       1                                              
  ≥3/week                          135(70.7)        207(54.2)    2.04(1.41, 2.95)[\*](#t004fn001){ref-type="table-fn"}   1.33(0.72, 2.47)                                        0.36                                           
  MUAC                             \<23             96(50.3)     58(15.2)                                                5.72(3.84, 8.53)[\*](#t004fn001){ref-type="table-fn"}   3.42(2.07, 5.63)                               \<0.001[\*\*](#t004fn002){ref-type="table-fn"}
  ≥23                              95(49.7)         324(84.8)    1                                                       1                                                       [\*](#t004fn001){ref-type="table-fn"}          
  DDS                              Low              57(30)       26(6.8)                                                 27.13(11.5,63.9[\*](#t004fn001){ref-type="table-fn"}    12.3(4.64, 32.72)                              \<0.001[\*\*](#t004fn002){ref-type="table-fn"}
  Medium                           126(66)          257(67.3)    6(2.86,12.86)[\*](#t004fn001){ref-type="table-fn"}      3.40(1.48, 7.84)                                        [\*](#t004fn001){ref-type="table-fn"}          
  High                             8(4.2)           99(25.9)     1                                                       1                                                       0.004[\*\*](#t004fn002){ref-type="table-fn"}   
  *Ascaris Lumbricoides*           Yes              29(15.2)     12(3.14)                                                5.57(2.7, 11.19)[\*](#t004fn001){ref-type="table-fn"}   6.81(3.35,13.85)                               \<0.001[\*\*\*](#t004fn003){ref-type="table-fn"}
  No                               47(24.6)         13(3.4)      1                                                       1                                                                                                      
  *Tricuris Trichiura*             Yes              14(7.3)      5(1.3)                                                  6.01(2.13,16.96[\*](#t004fn001){ref-type="table-fn"}    8.12(2.85, 23.16)                              \<0.001[\*\*\*](#t004fn003){ref-type="table-fn"}
  No                               176(92)          378(98.9)    1                                                       1                                                                                                      
  *Hookworm*                       Yes              27(14)       6(1.57)                                                 4.17(1.24, 14.0)[\*](#t004fn001){ref-type="table-fn"}   13(5.24,32.45)                                 \<0.001[\*\*\*](#t004fn003){ref-type="table-fn"}
  No                               49(25.6)         19(4.97)     1                                                       1                                                                                                      
  *Hymenolepis nana*               Yes              8(4.2)       4(1)                                                    10.41(4.22, 25.7)                                       4.88(1.38, 17.14)                              0.01[\*](#t004fn001){ref-type="table-fn"}
  No                               68(35.6)         21(5.49)     1                                                       1                                                                                                      

\*P \< 0.05

\*\*P\< 0.01

\*\*\*P\< 0.001

MUAC: Mid-upper arm circumference, DDS: Dietary diversity score

Anemia was almost 6 times more common among pregnant women who had intestinal helminthic infection than those with no intestinal helminthic infection (AOR = 6.31, 95%CI: 3.44, 11.58). Pregnant women infected with *Ascaris Lumbricoides*, *Tricuris Trichiura*, Hookworm and *Hymenolepis nana* were significantly affected by anemia (AOR = 6.81, 95%CI: 3.35, 13.85, AOR = 8.12, 95% CI: 2.85, 23.16, AOR = 13.03, 95%CI: 5.24, 32.45, AOR = 4.88, 95%CI: 1.38, 17.14), respectively (**[Table 4](#pone.0224514.t004){ref-type="table"})**.

Discussion {#sec023}
==========

Anemia is one of the most public health important diseases among pregnant women in Ethiopia \[[@pone.0224514.ref009]\] and in developing countries in general \[[@pone.0224514.ref020]\]. Anemia has multifactorial causes and the risk factors are different across populations. Here we identified six determinants of anemia among pregnant women who were attending ANC in the specific study sites.

More than half of anemic pregnant women had a mild type of anemia which was followed by moderate and severe anemia in this study. This is comparative with the studies conducted in Asosa zone, Gilgel Gibe dam area, and East Wollega Zone, Ethiopia \[[@pone.0224514.ref021], [@pone.0224514.ref022] and [@pone.0224514.ref023]\]. But, it is not comparative with the studies conducted in Tikur Anbessa Specialized hospital, Wolayita Sodo town and Mekelle town, Ethiopia \[[@pone.0224514.ref005], [@pone.0224514.ref010], and [@pone.0224514.ref024]\]. This difference might be due to the difference in determinants of anemia from one geographic area to another geographical area and sample size of the studies. Further, the differences in study design could also contribute to the observed inconsistencies.

An average monthly income of the household was identified as a significant predictor of anemia among pregnant women in this study. This finding is consistent with another study conducted in Azezo health center and Sidama Zone, Ethiopia \[[@pone.0224514.ref006], [@pone.0224514.ref025]\]. In contrast, this finding is different from a study done at Nekemte health center, Gilgel Gibe dam area, Buta Jira General Hospital, and Dera district, Ethiopia \[[@pone.0224514.ref011], [@pone.0224514.ref022], [@pone.0224514.ref026] and [@pone.0224514.ref027]\]. This difference could possibly be due to the difference in the economic status among the participants as low family income leads to food insecurity with the consequence of malnutrition which in turn leads to iron deficiency anemia \[[@pone.0224514.ref028]\].

Heavy menstrual bleeding (using more than seven sanitary pads per menstrual period) before the current pregnancy was identified as one independent factor for the occurrence of anemia among pregnant women. Anemic pregnant women who had heavy menstrual bleeding were almost twice of their counterparts in this study. This finding is in agreement with a study conducted at the Federal Medical Center Owemi, Nigeria \[[@pone.0224514.ref029]\], Otona Hospital, Wolayita Soddo town and Buta Jira hospital, Ethiopia \[[@pone.0224514.ref010], [@pone.0224514.ref026]\]. Excess blood flow leads to iron storage depletion and causes iron deficiency anemia which commonly occurs in pregnant women with short interbirth intervals.

Irregular use of iron supplements was identified as one of the determinants of anemia in the current study which is comparative with reports from East Wollega, Ethiopia \[[@pone.0224514.ref023]\], Kathmandu tertiary level hospital in the United States \[[@pone.0224514.ref030]\] and Pumwani maternity hospital in Kenya \[[@pone.0224514.ref031]\]. Regular use of iron supplements is vital to prevent anemia as the demand for iron is higher due to the increased blood supply during pregnancy.

Pregnant women with mid-upper arm circumference (MUAC) less than 23 cm (malnourished) were more at risk of being anemic. This finding is in line with the results of the studies conducted in Kenya \[[@pone.0224514.ref031]\] and other parts of Ethiopia like Gilgel Gibe dam area, Dessie town, and urban areas of east Ethiopia \[[@pone.0224514.ref022], [@pone.0224514.ref032], and [@pone.0224514.ref033]\]. Measuring MUAC is a routine activity for screening malnutrition during ANC follow up in Ethiopia. Malnutrition is one of the commonest contributing factors for iron deficiency anemia.

Pregnant women with low (≤3) and medium (4--6) dietary diversity score were more at risk of developing anemia when compared with those with dietary diversity score \>6. This finding was supported by a study conducted in Mekele town, Ethiopia \[[@pone.0224514.ref024]\] and another study conducted from South Ethiopia \[[@pone.0224514.ref034]\]. Minimum dietary diversity score (MDDS) is used as the proxy measure of nutritional quality of pregnant women. Since pregnancy is a period demanding physiologically high nutrition, it is advisable to diversify the diet than the usual one. Low average monthly income and food taboos during pregnancy in rural communities might cause this low and medium dietary diversity scores in the study area which in turn result in anemia.

Consistent with previous studies conducted in different regions of the world; Kenya \[[@pone.0224514.ref031]\], India \[[@pone.0224514.ref035]\] and Nigeria \[[@pone.0224514.ref036]\], and other parts of Ethiopia \[[@pone.0224514.ref010], [@pone.0224514.ref023], [@pone.0224514.ref029],[@pone.0224514.ref037]\], intestinal helminthic infection was one strong driving factor of anemia during pregnancy in the current study. *Ascaris Lumbricoides* and Hookworms were the predominant intestinal helminths infections among pregnant women in the current study. This finding is comparable with the studies conducted in East Wollega zone and Lemo district, Ethiopia \[[@pone.0224514.ref023], [@pone.0224514.ref034]\]. Intestinal helminths cause loss of appetite, reduce absorption, bleeding and share food uptake which in turn leads to iron deficiency anemia. Since the majority of the study participants were farmers and rural residents, they had a high chance of exposure to these intestinal helminthic infections due to walking barefooted and poor hygiene of food and water.

In contrary to the current study, variables like age, residence, family size, ANC follow up, trimester, malaria infection and interbirth interval showed statistically significant association with anemia among pregnant women in the previous studies conducted in Ethiopia \[[@pone.0224514.ref010], [@pone.0224514.ref021], [@pone.0224514.ref032], [@pone.0224514.ref033], [@pone.0224514.ref038] and [@pone.0224514.ref039]\]. This difference might be due to the fact that determinants of anemia varied from one geographical area to another geographical area due to the differences in the nutritional, altitudinal, economic and educational status of the study participants.

The study was facility-based which couldn't be generalized to all pregnant women left in the community (didn't attend antenatal care follow up). Dietary diversity score of 24 hours recall might leads to recall bias and the amount of diet also couldn't be measured. There might also be a social desirability problem to explain income level and some foods that were seen as low food status within the community. Having these limitations, we believe that the results of this study can contribute to policymakers and clinicians to prevent anemia during pregnancy.

Conclusion {#sec024}
==========

This study identified determinants of anemia among pregnant women in the study area. Average monthly income \< 500 ETB, heavy menstrual bleeding before the index pregnancy, low and medium dietary diversity score, MUAC \< 23 cm, taking iron supplementation irregularly and intestinal helminthic infections were identified as independent predictors of anemia. Early identification of determinants of anemia and appropriate interventions have paramount importance in fighting anemia to help mothers enjoy their pregnancy. Strengthening health education and counseling on diversifying dietary intake, increasing inter birth interval, routine stool examination, de-worming, and hygiene are valuable. Further large scale community-based studies are recommended.

Supporting information {#sec025}
======================

###### Supporting information 1: Supporting Tables Table A and Table B.

(DOCX)

###### 

Click here for additional data file.

###### Supporting information 2: Questionnaires used to collect data from pregnant women.

(DOCX)

###### 

Click here for additional data file.

We would like to acknowledge Wollega University administrative assistance to conduct this research. Lastly, but not the least, our special thanks and sincere appreciation also go to all data collectors, supervisors and study participants without whom the research would not be a reality.

10.1371/journal.pone.0224514.r001

Decision Letter 0

Glover-Amengor

Mary

Academic Editor

© 2019 Mary Glover-Amengor

2019

Mary Glover-Amengor

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

31 Jul 2019

PONE-D-19-15457

Determinants of Anemia among Pregnant Women Attending Antenatal Care in Horo Guduru Wollega Zone, West Ethiopia: Unmatched case-control study

PLOS ONE

Dear  Mr. Mengist,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. 

The manuscript sounds like a replication of work done in other districts of Ethiopia.Literature review should be expanded to include work done outside Ethiopia. Your English should be edited. Make a conscious effort to read and correct all the grammatical errors in the manuscript.

We would appreciate receiving your revised manuscript by August 14, 2019.. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Mary Glover-Amengor

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (<http://learn.aje.com/plos/>) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website ([www.editage.com](http://www.editage.com)) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

The name of the colleague or the details of the professional service that edited your manuscriptA copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a \*supporting information\* file)A clean copy of the edited manuscript (uploaded as the new \*manuscript\* file)

3\. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. Moreover, please include more details on how the questionnaire was pre-tested, and whether it was validated.

4\. Please correct your reference to \"p=0.000\" to \"p\<0.001\" or as similarly appropriate, as p values cannot equal zero.

5\. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see <http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions>.

In your revised cover letter, please address the following prompts:

a\) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b\) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see <http://www.bmj.com/content/340/bmj.c181.long> for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see <http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories>.

We will update your Data Availability statement on your behalf to reflect the information you provide.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: No

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: No

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This article is on the determinants for anemia in pregnant women in Ethiopia.

The study design includes a case-control study.

This article includes some limitations.

Women were recruited at ANC visit. The inclusion criteria were unclear especially regarding which ANC visit. What was the gestational age at inclusion? How was gestational age assessed? These are important criterias to mention and to discuss: Hb changes over the course of pregnancy (Ouedraogo et al.). Different cut-offs have been proposed according to the timing in pregnancy. This is not explained nor discussed, although this introduces some change in women included or not in the case/control group.

Also, what are guidelines in Ethiopia regarding anemia, malaria, iron/folic acid supplements, treatments for helminths, and their timing of administration? That would influence the level of anemia according to gestational age, and risk factors according to gestational age.

Some parts are too detailed for a scientific article. For example, data quality control, SOPs, etc. As well as some parts of data analysis.

100% response rate: this is strange. All women accepted to participate?

Severity of anemia should be described.

The language should be revised.

The results should refer to the tables explicitly. The p-value should be added in the tables were appropriate.

Some abbreviations in the tables are not explained (for example, MUAC, DDS).

Intestinal helminthic infections and the type of helminths infection are both included in the multivariate analyses, as presented. However, they are highly correlated, and it makes no sense to include both of them.

The number of tables should be reduced.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0224514.r002

Author response to Decision Letter 0

13 Aug 2019

Dear editor and reviewers

PONE-D-19-15457

Determinants of Anemia among Pregnant Women Attending Antenatal Care in Horo Guduru Wollega Zone, West Ethiopia: Unmatched case-control study

First of all, we would like to thank you for providing the reviewers' comments which are very constructive and crucial. We have incorporated all the point by point below. We have formatted the manuscript based on the PLOSONE guidelines. We have edited the English language online since we cannot afford to pay for editing agents. We have cleaned the manuscript as well. We have marked "red" the changes made in the manuscript and we have a separate file for "manuscript with track changes" and "clean manuscript". We have also attached a "rebuttal letter" which responds editor and reviewers' comments and/suggestions point by point. Further another document is also added as additional material to minimize the number of tables.

Response to editor
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There is still a major comment which is gestational age at enrolment. Gestational age at enrolment should be described. Indeed, the definition of anemia changes over pregnancy, and iron supplementts, anti-helminthic treatments, IPTp, etc are prescribed to the women during pregnancy. Thus, depending on the timing during pregnancy of enrolment in the study, risk factors may change. This should be discussed in the manuscript.
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1\. There is still a major comment which is gestational age at enrolment. Gestational age at enrolment should be described. Indeed, the definition of anemia changes over pregnancy, and iron supplementts, anti-helminthic treatments, IPTp, etc are prescribed to the women during pregnancy. Thus, depending on the timing during pregnancy of enrolment in the study, risk factors may change. This should be discussed in the manuscript.

Response: Pregnant women at any gestational age (GA) were included in the study. GA of pregnant women was classified into trimesters i.e. GA below 12 weeks: first trimester, GA of 13- 24 weeks: second trimester and GA above 24 weeks: third trimester. The gestational age was calculated from last normal menstrual period (LNMP) which was determined by antenatal care providers. In Ethiopia, health extension workers register pregnant women of any GA with their last normal menstrual period at home, thus, GA is not usually missed. The proportion of gestational age among the study participants is already described in the manuscript and supporting files.

GA was not a significant predictor of anemia among cases and multicollinearity test was done by using VIF to assess presence of collinearity among independent variables and the value of VIF was within the acceptable range which showed no collinearity. Therefore, there was no correlation between GA and other risk factors of anemia in our study which means the risk factors of anemia were not changeable based on differences in gestational age.
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